LEUPROLIDE for Hormone-refractory prostate cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 262 adverse event reports in the FDA FAERS database where LEUPROLIDE was used for Hormone-refractory prostate cancer.

Most Reported Side Effects for LEUPROLIDE

Side Effect	Reports	%	Deaths	Hosp.
Hot flush	9,146	12.9%	189	604
Death	8,772	12.4%	8,757	739
Intercepted product preparation error	8,621	12.2%	5	6
Syringe issue	7,847	11.1%	9	12
Device leakage	5,861	8.3%	7	8
Wrong technique in product usage process	5,062	7.1%	6	14
Fatigue	4,805	6.8%	223	631
Injection site pain	4,678	6.6%	174	281
Prostatic specific antigen increased	2,432	3.4%	225	297
Asthenia	2,176	3.1%	216	578
Off label use	2,060	2.9%	73	221
Drug ineffective	2,057	2.9%	97	218
Fall	1,922	2.7%	272	1,130
Arthralgia	1,756	2.5%	66	225
Prostate cancer	1,736	2.5%	836	306